Skip to main content

Biotech ETFs Slip as Trump Administration Pushes for Cheap Drug Imports

Biotechnology sector ETFs weakened Wednesday as the Trump administration pushes forward plans to allow the importation of cheaper drugs in an attempt to create greater competition in response to the rising costs of U.S. drugs. The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.